Neurology® Journal Club: Duration of Current Statin Use and Amyotrophic Lateral Sclerosis Risk

Area of Science:

• Neurology
• Pharmacology
• Epidemiology

Background:

• Conflicting evidence exists regarding statin use and amyotrophic lateral sclerosis (ALS) risk.
• Millions of adults use statins for cardiovascular health, raising concerns about potential neurological side effects.

Purpose of the Study:

• To critically appraise the study by Nakken et al. on the association between statin use duration and ALS risk.
• To evaluate the relationship between statin use patterns and subsequent ALS risk using population-based data.

Main Methods:

• Utilized linked nationwide health survey and prescription data from Norway.
• Employed time-dependent models, including time-dependent Cox modeling, to assess statin use and ALS risk.
• Incorporated a negative control as a key strength of the study design.

Main Results:

• Short-term statin use was associated with an increased risk of ALS.
• Long-term statin use was associated with a decreased risk of ALS.
• The authors proposed reverse causation as the most plausible explanation for the observed associations.

Conclusions:

• The findings suggest that the observed associations between statin use and ALS risk may be due to reverse causation.
• Acknowledges limitations inherent in observational studies, including potential residual confounding.
• Highlights the importance of considering study design and statistical methods in interpreting results on statin use and ALS.